Veronica Miller is an Adjunct Professor. Miller is an expert in regulatory science, publishing over 145 peer-reviewed publications on HIV treatment and regulatory strategies for HIV, HCV, HBV, CMV, liver diseases and rare diseases throughout her career.
Address: 1608 Rhode Island Ave, Suite 212
Washington DC 20036
Phone: (202) 974-6290
Biography
Veronica Miller, PhD, is an Adjunct Professor at Berkeley Public Health and Director of the Forum for Collaborative Research, a collaboration between industry, regulatory agencies, patients, and public health/clinical researchers to advance regulatory science and accelerate drug development in areas of unmet medical need. The Forum applies innovative translational medicine approaches to specific disease areas, such as viral infections, chronic diseases (steatotic and cholestatic disease of the liver) and ocular diseases requiring multi-modal approaches to generate solutions to high-prevalence complex, as well as rare, diseases. The approach involves multidisciplinary teams of experts in Public Health, Medicine, Biology, Statistics, Computer Science, Data Science and Regulatory Science to effect the last but crucial step in translational medicine to improve access to therapeutics and diagnostics worldwide. The Forum’s Data and Analysis Center is a cross-industry collaborative data-sharing platform to maximize the usefulness of clinical trial-generated data, including tissue/organ imaging, histopathology, radiology, and biomarkers spanning diverse contexts of use. The Forum DAC is made possible by Berkeley’s commitment to supporting infrastructure for sensitive patient-level data, and a forward-looking Office of Industry Alliance. The Forum offers unique educational opportunities for students and fellows interested in biotechnology. Veronica Miller is committed to educating the next generation of scientists through hands-on learning complemented by online and on-campus courses. She has over 145 peer reviewed publications.
Research Interests
Advancing regulatory science for unmet medical/public health needs
Collaborative frameworks for drug development
Translating biomedical innovation to global access
Disease areas: HIV, HCV, HBV, CMV, liver diseases
Education
Postdoctoral – Virology University of California, Los Angeles
Postdoctoral – Cell Biology University of New Mexico
PhD – Immunology University of Manitoba
BSc – Microbiology University of Manitoba
Courses Taught
PH 236
U.S. Food and Drug Administration, Drug Development, Public Health, and Health Policy
PHW236A
Regulatory Science, Drug Development and Public Health
PH290
Diagnostics in Infectious Diseases: Drug Development and Regulatory Challenges